LENZ Therapeutics (LENZ) Shares Outstanding (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Shares Outstanding (Entity) data on file, last reported at $31.4 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 13.84% year-over-year to $31.4 million in Q1 2026; TTM through Mar 2026 was $31.4 million, a 13.84% increase from a year earlier, with the FY2025 full-year figure at $31.3 million, up 47.29% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $31.4 million, roughly flat from $31.3 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for LENZ reached as high as $31.4 million in Q1 2026 and fell as low as $4.7 million in Q1 2024.
• Historically, Shares Outstanding (Entity) has averaged $17.2 million across 5 years, with a median of $8.3 million in 2022.
• Across the five-year window, Shares Outstanding (Entity) surged 1044.31% in 2022 and sank 43.26% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $8.3 million in 2022, then retreated by 0.37% to $8.3 million in 2023, then surged by 156.8% to $21.3 million in 2024, then jumped by 47.29% to $31.3 million in 2025, then gained by 0.03% to $31.4 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $31.4 million in Q1 2026, $31.3 million in Q4 2025, and $28.6 million in Q3 2025.